Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FOLFCIS regimen for treatment of cancer of the anal canal
    Meeting Abstract

    Mondaca, S.; Chatila, W. K.; Hechtman, J. F.; Bates, D.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Berger, M. F.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Balancing RAF, MEK, and EGFR inhibitor doses to achieve clinical responses and modulate toxicity in BRAF V600E colorectal cancer
    Journal Article

    Mondaca, S.; Lacouture, M.; Hersch, J.; Yaeger, R.
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Detecting MSI in plasma: Implications for early detection of lynch associated tumors
    Meeting Abstract

    Srinivasan, P.; Tran, C.; Reichel, J.; Patel, J. A.; Hasan, M.; Meng, F.; Jing, X.; Middha, S.; Zehir, A.; Yaeger, R. D.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Genomic characterization of organ-specific metastasis from prospective clinical sequencing of 20,000 cancer patients
    Meeting Abstract

    Sanchez-Vega, F.; Chatila, W. K.; Ganesh, K.; Penson, A.; Camacho, N.; Jonsson, P.; Reznik, E.; Gao, J. J.; Yaeger, R.; Berger, M. F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Intermittent treatment with MEK inhibitors in patients with oncogenic RAF-driven tumors: A potential strategy to manage toxicity and maintain efficacy
    Journal Article

    Yaeger, R.; Yao, Z.; Chapman, P. B.
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
    Meeting Abstract

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; Torres, N.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save